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life. J Vasc Surg 2002;35:1197-203.Submitted Oct 11, 2012; accepted Dec 13, 2012.INVITED COMMENTARYJoseph D. Raffetto, MD, West Roxbury, MassIn this study, Rasmussen et al provide a 5-year follow-up of the
original randomized trial in which endovenous ablation was
compared with ligation and stripping of the great saphenous vein
in symptomatic patients with varicose veins that was published after
2 years of follow-up.1 The importance of long-term data demon-
strating durability and patient satisfaction after venous surgery is
imperative and was previously demonstrated by Merchant et al2 in
a multicenter prospective registry.
For many years, it has been presumed that endovenous abla-
tive techniques should be the primary treatment modality for the
reﬂuxing great saphenous vein and completely replace ligation
and stripping. This contention was speculative and without scien-
tiﬁc evidence. A small randomized trial by Lurie et al3 in which
endovenous radiofrequency ablation was compared with surgical
ligation and stripping demonstrated that at 2 years of follow-up,
in addition to similar treatment success and reduction in clinical
severity, the endovenous ablation group had signiﬁcantly reduced
pain as a quality-of-life dimension compared with surgery that per-
sisted up to 2 years.
Similar to the Lurie trial, the uniqueness of this study,
however, is that it compares a well-validated surgical techniqued
ligation and strippingdwith a relatively new treatment modality
encompassing endovenous laser ablation, with important primary
and secondary end points that mattered not only to the clinician
but also to the patient and over a long period of post-treatment
duration. Rasmussen et al found that both therapies were effective
and had no differences in recurrent reﬂuxing great saphenous vein,
recurrent varicose veins, clinical severity, and quality-of-life analysis.
The strength in any study evaluating long-term results is the
sample size in each group studied and the actual number of evaluablepatients at each year interval, and in this study, at the 5-year follow-
up. In addition to patient recruitment, understandably not all
patients will be available to evaluate, and in this study, the authors
recognize these limitations. However, this should not take away
from the signiﬁcance of this well-designed study, with well-
matched groups and relevant end points that are critically important
in clinical practice for physician caring for patients with venous
disease. Although our conﬁdence in treating patients with varicose
veins with less invasive modalities will increase, there is a barrage of
other modalities that have not been studied in a carefully designed
randomized trial that await bothprofessional and clinical acceptance.
I believe the study by Rasmussen et al has set the framework for
further work in this important ﬁeld, that will answer which treat-
ments, which outcomes, and what follow-up is necessary in deter-
mining best treatment practices for patients with varicose veins.REFERENCES
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